z-logo
Premium
NK 1 ‐receptors mediate the proliferative response of human fibroblasts to tachykinins
Author(s) -
Ziche Marina,
Morbidelli Lucia,
Pacini Marco,
Dolara Piero,
Maggi Carlo Alberto
Publication year - 1990
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1990.tb12043.x
Subject(s) - substance p , neurokinin b , neurokinin a , tachykinin receptor , receptor , medicine , endocrinology , agonist , cell growth , fibroblast , tachykinin receptor 1 , biology , chemistry , cell culture , neuropeptide , biochemistry , genetics
1 The effect of synthetic tachykinin selective receptor agonists was studied on the growth of cultured human skin fibroblasts (HF). 2 Human fibroblasts were grown in serum‐free conditions in the presence of natural tachykinins (substance P and neurokinin A) and of three synthetic agonists, [β‐Ala 4 , Sar 9 , Met(O 2 ) 11 ]‐SP(4–11), [β‐Ala 8 ]‐NKA(4–10) and [MePhe 7 ]‐NKB selective for NK 1 ‐, NK 2 ‐ and NK 3 ‐receptors respectively. Cell proliferation was measured by percentage increase in cell number and by [ 3 H]‐thymidine uptake following 48 h exposure to agents compared to baseline condition. 3 Neurokinin A (NKA) and substance P (SP) significantly increased cell proliferation the threshold concentrations being 10 −12 and 10 −11 m , respectively. Addition of thiorphan to culture conditions enhanced the effect of SP but not of NKA. 4 The selective NK 1 ‐receptor agonist produced a dose‐dependent increase in cell proliferation as judged by total cell number and [ 3 H]‐thymidine uptake. No significant effect was observed with NK 2 ‐ and NK 3 ‐receptor agonists. 5 These data indicate that the effect of SP on fibroblast proliferation is mediated by interaction with a NK 1 ‐receptor type and local metabolism can interfere with the full expression of this effect of SP on cell proliferation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here